EUVIMEDEUVIMED entdecken
Open Access

Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor‐Associated Hypertension

Zhe Ye, Ryuji Okamoto iD, Hiromasa Ito, Rie Ito, Keishi Moriwaki iD, Mizuki Ichikawa, Lupiya Kimena iD, Yusuf Ali iD, Masaaki Ito iD, Celso E Gomez-Sanchez iD, Kaoru Dohi iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.032828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Zhe Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Nephrology Mie University Graduate School of Medicine Tsu Mie Japan. Hauptthemen laut MEDLINE: Hypertension, Myosin-Light-Chain Phosphatase. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myosin phosphatase targeting subunit 2 (MYPT2) is an important subunit of cardiac MLC (myosin light chain) phosphatase, which plays a crucial role in regulating the phosphorylation of MLC to phospho‐MLC (p‐MLC). A recent study demonstrated mineralocorticoid receptor‐related hypertension is associated with RhoA/Rho‐associated kinase/MYPT1 signaling upregulation in smooth muscle cells. Our purpose is to investigate the effect of MYPT2 on cardiac function and fibrosis in mineralocorticoid receptor‐related hypertension. Methods and Results HL‐1 murine cardiomyocytes were incubated with different concentrations or durations of aldosterone. After 24‐hour stimulation, aldosterone increased CTGF (connective tissue growth factor) and MYPT2 and decreased p‐MLC in a dose‐dependent manner. MYPT2 knockdown decreased CTGF. Cardiac‐specific MYPT2‐knockout (c‐MYPT2 −/− ) mice exhibited decreased type 1 phosphatase catalytic subunit β and increased p‐MLC. A disease model of mouse was induced by subcutaneous aldosterone and 8% NaCl food for 4 weeks after uninephrectomy. Blood pressure elevation and left ventricular hypertrophy were observed in both c‐MYPT2 −/− and MYPT2 +/+ mice, with no difference in heart weights or nuclear localization of mineralocorticoid receptor in cardiomyocytes. However, c‐MYPT2 −/− mice had higher ejection fraction and fractional shortening on echocardiography after aldosterone treatment. Histopathology revealed less fibrosis, reduced CTGF, and increased p‐MLC in c‐MYPT2 −/− mice. Basal global radial strain and global longitudinal strain were higher in c‐MYPT2 −/− than in MYPT2 +/+ mice. After aldosterone treatment, both global radial strain and global longitudinal strain remained higher in c‐MYPT2 −/− mice compared with MYPT2 +/+ mice.

Conclusions

Cardiac‐specific MYPT2 knockout leads to decreased myosin light chain phosphatase and increased p‐MLC. MYPT2 deletion prevented cardiac fibrosis and dysfunction in a model of mineralocorticoid receptor‐associated hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionMyosin-Light-Chain PhosphataseAnimalsMiceAldosteroneFibrosisMyocytes, CardiacPhosphorylationReceptors, Mineralocorticoid

Stichwörter der Autor:innen

aldosteronecardiac fibrosismineralocorticoid receptormyosin light chainphosphorylation

Substanzen

AldosteroneMyosin-Light-Chain PhosphataseReceptors, MineralocorticoidPpp1r12a protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology and Nephrology Mie University Graduate School of Medicine Tsu Mie Japan.
  • Regional Medical Support Center Mie University Hospital Tsu Mie Japan.
  • Department of Clinical Training and Career Support Center Mie University Hospital Tsu Mie Japan.
  • Department of Pharmacology and Toxicology University of Mississippi Medical Center Jackson MS.

ORCID-Profile: Ryuji Okamoto, Keishi Moriwaki, Lupiya Kimena, Yusuf Ali, Masaaki Ito, Celso E Gomez-Sanchez, Kaoru Dohi

Förderung

  • BLRD VA
  • NHLBI NIH HHS

Zitieren

APA

Ye, Z., Okamoto, R., Ito, H., Ito, R., Moriwaki, K., Ichikawa, M., Kimena, L., Ali, Y., Ito, M., Gomez-Sanchez, C. E., & Dohi, K. (2024). Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor‐Associated Hypertension. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032828

Vancouver

Ye Z, Okamoto R, Ito H, Ito R, Moriwaki K, Ichikawa M, et al. Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor‐Associated Hypertension. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032828

BibTeX
@article{Ye2024,
  author = {Ye, Zhe and Okamoto, Ryuji and Ito, Hiromasa and Ito, Rie and Moriwaki, Keishi and Ichikawa, Mizuki and Kimena, Lupiya and Ali, Yusuf and Ito, Masaaki and Gomez-Sanchez, Celso E and Dohi, Kaoru},
  title = {Myosin Light Chain Phosphatase Plays an Important Role in Cardiac Fibrosis in a Model of Mineralocorticoid Receptor‐Associated Hypertension},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.032828}
}
Kostenlos starten →